GSK 2837808A | CAS 1445879-21-9 - Request Quote
GSK 2837808A
| SZ CAT No: | SZ-B027007 |
| CAS No | 1445879-21-9 |
| Mol.F. | C31H25F2N5O7S |
| Mol.Wt. | 649.1 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
GSK 2837808A is chemically Benzoic acid, 3-[[3-[(cyclopropylamino)sulfonyl]-7-(2,4-dimethoxy-5-pyrimidinyl)-4-quinolinyl]amino]-5-(3,5-difluorophenoxy)-; 3-[[3-[(Cyclopropylamino)sulfonyl]-7-(2,4-dimethoxy-5-pyrimidinyl)-4-quinolinyl]amino]-5-(3,5-difluorophenoxy)benzoic acid;. GSK 2837808A is supplied with detailed characterization data compliant with regulatory guideline. GSK 2837808A can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Benzoic Acid.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1445879-21-9
Purchase 1445879-21-9
Order 1445879-21-9
Enquire 1445879-21-9
price of 1445879-21-9
1445879-21-9 Supplier
1445879-21-9 Manufacturer
1445879-21-9 Exporter
buy high quality GSK 2837808A
Purchase GSK 2837808A
GSK 2837808A suppliers
GSK 2837808A manufacturers
GSK 2837808A price
Order GSK 2837808A
Enquire GSK 2837808A
GSK 2837808A cost
GSK 2837808A Supplier
GSK 2837808A Distributor
GSK 2837808A for Method Validation
Benzoic Acid Reference Standard
GSK 2837808A for ANDA Filing
GSK 2837808A for Forced Degradation Studies
GSK 2837808A Identification Standards
GSK 2837808A for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.